Literature DB >> 21914036

Fosfomycin: an old--new antibiotic.

R Raz1.   

Abstract

Fosfomycin is a broad-spectrum antibiotic discovered in Spain in 1969. It has bactericidal activity against a wide range of bacteria, including gram-negative micro-organisms and some gram-positive bacteria, such as staphylococci. Initially fosfomycin was administered parenterally and only to patients with severe infections. Today it is often dispensed as fosfomycin-trometamol, an oral formula recommended in the treatment of urinary tract infections. Fosfomycin-trometamol in a single dose is indicated for the treatment of women with uncomplicated urinary tract infections.
© 2011 The Author. Clinical Microbiology and Infection © 2011 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21914036     DOI: 10.1111/j.1469-0691.2011.03636.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  44 in total

1.  In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.

Authors:  James A Karlowsky; Andrew J Denisuik; Philippe R S Lagacé-Wiens; Heather J Adam; Melanie R Baxter; Daryl J Hoban; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2013-12-09       Impact factor: 5.191

2.  Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves.

Authors:  Robert K Flamm; Paul R Rhomberg; Jill M Lindley; Kim Sweeney; E J Ellis-Grosse; Dee Shortridge
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 3.  Insights into Newer Antimicrobial Agents Against Gram-negative Bacteria.

Authors:  Neelam Taneja; Harsimran Kaur
Journal:  Microbiol Insights       Date:  2016-03-20

4.  Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-β-lactamase-producing Escherichia coli in a foreign-body infection model.

Authors:  Stéphane Corvec; Ulrika Furustrand Tafin; Bertrand Betrisey; Olivier Borens; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

5.  Fosfomycin induced structural change in fosfomycin resistance kinases FomA: molecular dynamics and molecular docking studies.

Authors:  Yun-Jian Wu; Qing-Chuan Zheng; Ji-Long Zhang; Wen-Ting Chu; Ying-Lu Cui; Yan Wang; Hong-Xing Zhang
Journal:  J Mol Model       Date:  2014-04-27       Impact factor: 1.810

6.  High incidence and endemic spread of NDM-1-positive Enterobacteriaceae in Henan Province, China.

Authors:  Shangshang Qin; Ying Fu; Qijing Zhang; Hui Qi; Jian Guo Wen; Hui Xu; Lijuan Xu; Li Zeng; Hao Tian; Lijuan Rong; Yonghong Li; Lihong Shan; Hongde Xu; Yunsong Yu; Xianju Feng; Hong-Min Liu
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

7.  Blocking peptidoglycan recycling in Pseudomonas aeruginosa attenuates intrinsic resistance to fosfomycin.

Authors:  Marina Borisova; Jonathan Gisin; Christoph Mayer
Journal:  Microb Drug Resist       Date:  2014-05-12       Impact factor: 3.431

8.  High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.

Authors:  Raluca Mihailescu; Ulrika Furustrand Tafin; Stéphane Corvec; Alessandra Oliva; Bertrand Betrisey; Oliver Borens; Andrej Trampuz
Journal:  Antimicrob Agents Chemother       Date:  2014-02-18       Impact factor: 5.191

9.  Organoarsenicals inhibit bacterial peptidoglycan biosynthesis by targeting the essential enzyme MurA.

Authors:  Luis D Garbinski; Barry P Rosen; Masafumi Yoshinaga
Journal:  Chemosphere       Date:  2020-04-27       Impact factor: 7.086

10.  Evidence for radical-mediated catalysis by HppE: a study using cyclopropyl and methylenecyclopropyl substrate analogues.

Authors:  Hui Huang; Wei-chen Chang; Pei-Jing Pai; Anthony Romo; Steven O Mansoorabadi; David H Russell; Hung-wen Liu
Journal:  J Am Chem Soc       Date:  2012-09-24       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.